Cardiac Marker Testing Devices Have Become Critical For Early Diagnosis of Cardiovascular Disease and Measure Heart Function

 

Cardiac markers are special antibodies measured in the blood to measure heart function. They can also be used in the detection or early diagnosis of certain diseases. Although they're usually associated with myocardial infarction, they can also be indicative of many other conditions. For instance, hyperthyroidism and thyroid prophylaxis can result in an elevated elevation in plasma marker levels. As per the American Heart Association (AMA), in 2016, cardiovascular disease accounted for 17.6 million deaths across the globe. The ECG is one of the most useful cardiac marker testing device. It measures the cardiac output and provides detailed information about heart conditions. This test is used to diagnose heart diseases and the complications that can arise from the disease.

ECG is one of the most widely used tests. ECG is conducted while the patient is lying down on the table. A technician places electrodes either in or on the skin surface. The test is normally performed for different purposes. There are other reasons that the test is carried out like for instance, when there is no proper rhythm of the heartbeat, ventricular tachycardia, ventricular fibrillation, left ventricular failure, or congenital heart disease, to mention a few. Another procedure called the Doppler exam measures the intensity, wavelength, and duration of the beats of the heart. This procedure is usually carried out on the patient who has been diagnosed with acute myocardial ischemia and other Cardiac Complications.

As the technology that supports the monitoring of heart health continues to advance, it will be easier and more effective to monitor patients with cardiac disease and monitor their markers. Medical researchers have been able to develop several different cardiac marker testing device to measure these proteins and are developing new methods to keep up with the latest developments. Recently, in July 2018, Ortho Clinical Diagnostics, a U.S.-based company, launched new MicroTip partnership assays for diabetes, cardiac, and rental testing in collaboration with Diazyme Laboratories Inc.